Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

Showing results filtered by:
CLEAR ALL
Small Business (SBIR/STTR)
14 Results
Title Activity Code Posting Date Sort ascending Expiration Date
Multipurpose Prevention Technology—Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)- PAR-21-297 R43/R44 August 31, 2021 December 10, 2023
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)- PAR-21-247 R43/R44 July 12, 2021 June 16, 2023
PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-21-262 R41/R42 July 08, 2021 April 06, 2022
PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-21-259 R43/R44 July 08, 2021 April 06, 2022
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)- RFA-DK-21-021 R43/R44 June 25, 2021 October 08, 2022
Notice of Special Interest (NOSI)— HIV Drug Resistance Assays and Actionable Data Dissemination Strategies- NOT-AI-21-056 Multiple June 17, 2021 May 08, 2024
Notice of Special Interest (NOSI)—Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health- NOT-EB-21-001 R41/R42, R43/R44 February 22, 2021 April 06, 2023
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-21-082 U44 January 14, 2021 January 14, 2024
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late-Stage Development (SB1, Clinical Trial Not Allowed)- PAR-20-129 SB1 July 10, 2020 April 06, 2022
Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)- PAR-20-098 R43/R44 February 06, 2020 January 06, 2022
Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)- PAR-20-109 R41/R42 February 06, 2020 January 06, 2022
Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics- NOT-AI-20-013 R01, R21, R41/R42, R43/R44 December 17, 2019 January 08, 2023
Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)- NOT-AI-20-005 R01, R15, R41/R42, R43/R44 November 12, 2019 January 08, 2023
Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-19-001 Multiple March 13, 2019